• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于研究乳糜泻的人类肠道类器官模型。

Human intestinal organoid models for celiac disease research.

机构信息

Celiac Disease Research Center, Faculty of Medicine and Health Technology, Tampere University, Tampere University Hospital, Tampere, Finland.

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

出版信息

Methods Cell Biol. 2023;179:173-193. doi: 10.1016/bs.mcb.2023.01.008. Epub 2023 Feb 24.

DOI:10.1016/bs.mcb.2023.01.008
PMID:37625874
Abstract

Celiac disease pathogenesis, in addition to immune cell component, encompasses pathogenic events also in the duodenal epithelium. In celiac disease patients, exposure to dietary gluten induces drastic changes in epithelial differentiation and elicit cellular response to inflammatory cytokines. The autoantigen in celiac disease, transglutaminase 2 (TG2) enzyme, has been also suggested to play its pathogenic gliadin deamidation event in the intestinal epithelium. Therefore in vitro epithelial cell-line models have been exploited in the past to study these pathogenic mechanisms, but they are hampered by their simplistic nature lacking proper cell-type composition and intestinal environ. Moreover, these cell models harbor many cancer-related mutations in tumor suppressor genes making them unsuitable for studying cell differentiation. Intestinal organoids provide a near-native epithelial cell model to study pathogenic agents and mechanisms related to celiac disease. Here we describe protocols to initiate and maintain celiac patient-derived organoid cultures and how to grow them in alternative ways allowing their exploitation in different kind of experiments.

摘要

乳糜泻的发病机制除了免疫细胞成分外,还包括十二指肠上皮中的致病事件。在乳糜泻患者中,膳食 gluten 的暴露会引起上皮分化的剧烈变化,并引起对炎症细胞因子的细胞反应。乳糜泻中的自身抗原,转谷氨酰胺酶 2(TG2)酶,也被认为在肠上皮中发挥其致病的麦胶去酰胺作用。因此,过去曾利用体外上皮细胞系模型来研究这些致病机制,但它们受到自身简单性质的限制,缺乏适当的细胞类型组成和肠道环境。此外,这些细胞模型中存在许多肿瘤抑制基因的癌症相关突变,使它们不适合研究细胞分化。肠类器官提供了一种接近天然的上皮细胞模型,可用于研究与乳糜泻相关的致病因子和机制。在这里,我们描述了启动和维持乳糜泻患者来源的类器官培养的方案,以及如何以不同的方式生长它们,从而允许在不同类型的实验中利用它们。

相似文献

1
Human intestinal organoid models for celiac disease research.用于研究乳糜泻的人类肠道类器官模型。
Methods Cell Biol. 2023;179:173-193. doi: 10.1016/bs.mcb.2023.01.008. Epub 2023 Feb 24.
2
Human gut derived-organoids provide model to study gluten response and effects of microbiota-derived molecules in celiac disease.人类肠道衍生类器官为研究乳糜泻中麸质反应和微生物衍生分子的作用提供了模型。
Sci Rep. 2019 May 7;9(1):7029. doi: 10.1038/s41598-019-43426-w.
3
Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects.乳糜泻抗2型转谷氨酰胺酶抗体对乳糜泻患者和健康受试者的成纤维细胞产生不同影响。
Amino Acids. 2017 Mar;49(3):541-550. doi: 10.1007/s00726-016-2307-z. Epub 2016 Sep 9.
4
Cosilencing Intestinal Transglutaminase-2 and Interleukin-15 Using Gelatin-Based Nanoparticles in an in Vitro Model of Celiac Disease.基于明胶的纳米颗粒沉默肠转谷氨酰胺酶-2 和白细胞介素-15 在乳糜泻体外模型中的应用。
Mol Pharm. 2017 Sep 5;14(9):3036-3044. doi: 10.1021/acs.molpharmaceut.7b00233. Epub 2017 Aug 10.
5
Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.麸质酶 2 和麸质酶 2 自身抗体在乳糜泻中的研究进展。
Clin Rev Allergy Immunol. 2019 Aug;57(1):23-38. doi: 10.1007/s12016-016-8557-4.
6
Gliadin-dependent cytokine production in a bidimensional cellular model of celiac intestinal mucosa.在乳糜泻肠黏膜二维细胞模型中麦醇溶蛋白依赖性细胞因子的产生
Clin Exp Med. 2015 Nov;15(4):447-54. doi: 10.1007/s10238-014-0325-2. Epub 2014 Dec 2.
7
A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.转谷氨酰胺酶2介导的麸质肽脱酰胺作用的定量分析:对乳糜泻中T细胞反应的影响
J Proteome Res. 2009 Apr;8(4):1748-55. doi: 10.1021/pr800960n.
8
Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept study.转谷氨酰胺酶 2 抑制剂能否降低与乳糜泻相关的麦胶蛋白诱导的毒性?一项概念验证研究。
J Clin Immunol. 2013 Jan;33(1):134-42. doi: 10.1007/s10875-012-9745-5. Epub 2012 Aug 10.
9
Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?麸质酶 2 自身抗体在乳糜泻中的作用:除了诊断工具,还是致病因素?
Autoimmun Rev. 2010 Sep;9(11):744-9. doi: 10.1016/j.autrev.2010.06.003. Epub 2010 Jun 12.
10
Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease.转谷氨酰胺酶对麦醇溶蛋白肽的脱酰胺和交联作用及其与乳糜泻的关系。
Biochim Biophys Acta. 2004 Nov 5;1690(3):220-30. doi: 10.1016/j.bbadis.2004.06.009.

引用本文的文献

1
Sustainable milk-based postbiotics beverages fermented by : allies in celiac disease inflammation.由以下物质发酵而成的可持续牛奶基后生元饮料:乳糜泻炎症中的盟友。 (此译文感觉原英文表述不太完整准确,翻译出来稍显奇怪,但完全按照要求进行了翻译)
Front Nutr. 2025 May 13;12:1549120. doi: 10.3389/fnut.2025.1549120. eCollection 2025.
2
Advances and applications of gut organoids: modeling intestinal diseases and therapeutic development.肠道类器官的进展与应用:模拟肠道疾病及治疗开发
Life Med. 2025 Mar 7;4(2):lnaf012. doi: 10.1093/lifemedi/lnaf012. eCollection 2025 Apr.
3
Comparative proteomics analysis of the mouse mini-gut organoid: insights into markers of gluten challenge from celiac disease intestinal biopsies.
小鼠迷你肠道类器官的比较蛋白质组学分析:对来自乳糜泻肠道活检组织中麸质激发标志物的见解。
Front Mol Biosci. 2024 Aug 28;11:1446822. doi: 10.3389/fmolb.2024.1446822. eCollection 2024.
4
Cellular and molecular basis of proximal small intestine disorders.近端小肠疾病的细胞和分子基础。
Nat Rev Gastroenterol Hepatol. 2024 Oct;21(10):687-709. doi: 10.1038/s41575-024-00962-9. Epub 2024 Aug 8.
5
New Insights on Genes, Gluten, and Immunopathogenesis of Celiac Disease.新见解:乳糜泻的基因、 gluten 和免疫发病机制。
Gastroenterology. 2024 Jun;167(1):4-22. doi: 10.1053/j.gastro.2024.03.042. Epub 2024 Apr 24.
6
The Oral Transglutaminase 2 Inhibitor ZED1227 Accumulates in the Villous Enterocytes in Celiac Disease Patients during Gluten Challenge and Drug Treatment.口面谷氨酰胺酶 2 抑制剂 ZED1227 在乳糜泻患者接受麸质挑战和药物治疗期间在绒毛肠细胞中积累。
Int J Mol Sci. 2023 Jun 28;24(13):10815. doi: 10.3390/ijms241310815.